COVaRiPad study - Immunosuppression affects COVID-19 vax Ab levels. 247 pts, 90% seroconverted but @ reduced (3.4 fold)

Social Author Image

https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3.jpg

Tweet Author

Social Author Name

Dr. John Cush

Tweet Content

COVaRiPad study - Immunosuppression affects COVID-19 vax Ab levels. 247 pts, 90% seroconverted but @ reduced (3.4 fold) titers. Lowest w/ MMF (21x) and B cell Rx vs MTX/AZA (3-4x). Pts on B cell therapy should wait 6 mos to recv vax #ACR21 Abstr# 0457 https://t.co/1gkCsJSDBk

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

COVaRiPad study - Immunosuppression affects COVID-19 vax Ab levels. 247 pts, 90% seroconverted but @ reduced (3.4 fold)

Do you get our email newsletter?